Company performance
Add to research
Current Price
as of Apr 17, 2025$172.99
P/E Ratio
72.37
Market Cap
$306.02B
Loading...
Description
Add to research
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Metrics
Add to research
Overview
- HQNorth Chicago, IL
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerABBV
- Price$172.99+0.76%
Trading Information
- Market cap$306.02B
- Float99.89%
- Average Daily Volume (1m)9,779,070
- Average Daily Volume (3m)7,456,345
- EPS$2.40
Company
- Revenue$56.33B
- Rev growth (1yr)3.71%
- Net income$4.24B
- Gross margin78.07%
- EBITDA margin44.40%
- EBITDA$25.01B
- EV$377.39B
- EV/Revenue6.70
- P/E72.37
- P/S5.44
- P/B91.84
- Debt/Equity2,040.33
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset